Fineline Cube

Follow:
14475 Articles
Company

Shanghai Pharmaceuticals Posts 5.14% YOY Revenue Growth in 2024H1 with Focus on Cell Therapies

Company

Innovent Biologics’ President Liu Yongjun Resigns, CEO De-Chao Micheal Yu Takes R&D Reins

CompanyDeals

Fosun Pharma’s Privatization of Henlius Includes Cash and Share Offers, Aims for Full Equity Control

CompanyDrug

China’s CDE Approves Multitude Therapeutics’ AMT-676 for Clinical Study in Solid Tumors

CompanyMedical Device

Chinese NMPA Grants License to MicroPort Endovascular MedTech’s Venous Stent for Treating Vascular Conditions

CompanyDrug

Mabwell Bioscience Initiates Phase III Trial for 9MW2821 Combo in Urothelial Carcinoma Following NMPA Clearance

Company

CStone Pharmaceuticals Reports 2024 Interim Results with Strategic Collaborations and Regulatory Milestones

CompanyDeals

Suzhou-Based Medical Device Innovator Ensurge Secures RMB 100 Million in Latest Financing Round

CompanyDrug

US FDA Approves Updated COVID-19 mRNA Vaccines from Pfizer/BioNTech and Moderna Ahead of Winter

Company

Guangzhou-Based Bio-Thera Solutions Expands Market Presence with Biosimilars and Innovative Drug Approvals

CompanyMedical Device

National Healthcare Security Administration Reports Pricing Revisions on Aortic Stent Grafts by Major Manufacturers

CompanyDrug

Shouyao Holdings Receives Clinical Trial Approval for SY-7166 in Treating Multiple Myeloma